AIZN Q1 2026 Earnings Subordinated Notes Benefit as Core Earnings Surpass Estimates by 1127 ESAB Q1 2026 Earnings EPS Miss Weighs on Sentiment Despite Resilient Operations SAH Q1 2026 Earnings Strong EPS Beat Drives 62 Stock Surge ATNM Q1 2026 Earnings NarrowerthanExpected Loss Highlights Controlled Spending Amid Clinical Progress GT Biopharma Q1 2026 Earnings Wider Loss and No Revenue as Pipeline Progress Remains Uncertain CCLD Q1 2026 Earnings EPS Misses Estimates by Wide Margin Stock Declines